RENEO PHARMACEUTICALS INC's ticker is RPHM and the CUSIP is 75974E103. A total of 36 filers reported holding RENEO PHARMACEUTICALS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.7%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $915,749 | +39.5% | 120,256 | +20.2% | 0.00% | – |
| Q2 2023 | $656,531 | +630.4% | 100,081 | +565.8% | 0.00% | – |
| Q1 2023 | $89,891 | +224.0% | 15,032 | +26.2% | 0.00% | – |
| Q4 2022 | $27,743 | -30.6% | 11,907 | 0.0% | 0.00% | – |
| Q3 2022 | $40,000 | +29.0% | 11,907 | 0.0% | 0.00% | – |
| Q2 2022 | $31,000 | -84.6% | 11,907 | -82.6% | 0.00% | – |
| Q1 2022 | $201,000 | -63.1% | 68,424 | +7.7% | 0.00% | – |
| Q4 2021 | $544,000 | +23.9% | 63,547 | +7.7% | 0.00% | – |
| Q3 2021 | $439,000 | -31.3% | 59,029 | -13.8% | 0.00% | – |
| Q2 2021 | $639,000 | – | 68,447 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RiverVest Venture Management LLC | 2,409,220 | $7,083,000 | 7.27% |
| Abingworth LLP | 2,073,957 | $6,077,000 | 1.72% |
| Aisling Capital Management LP | 886,075 | $2,605,000 | 1.41% |
| Novo Holdings A/S | 3,430,377 | $10,085,000 | 0.53% |
| NEA Management Company, LLC | 4,786,921 | $14,073,000 | 0.41% |
| TYBOURNE CAPITAL MANAGEMENT (HK) LTD | 700,000 | $2,058,000 | 0.12% |
| Rock Springs Capital Management LP | 1,143,185 | $3,361,000 | 0.08% |
| Ikarian Capital, LLC | 185,597 | $546,000 | 0.07% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 100,000 | $294,000 | 0.01% |
| BOOTHBAY FUND MANAGEMENT, LLC | 17,648 | $52,000 | 0.00% |